Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?

door Al-Kassmy, Jawad, Pedersen, Jannie, Kobinger, Gary
Gepubliceerd in Viruses (2020)

Inflammatory pathways of importance for management of inflammatory bowel disease

door Pedersen, Jannie, Coskun, Mehmet, Soendergaard, Christoffer, Salem, Mohammad, Nielsen, Ole Haagen
Gepubliceerd in 2014

Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c

door Ramirez, Santseharay, Fernandez-Antunez, Carlota, Mikkelsen, Lotte S., Pedersen, Jannie, Li, Yi-Ping, Bukh, Jens
Gepubliceerd in Antimicrob Agents Chemother (2020)

Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome

door Pedersen, Jannie, Jensen, Tanja B., Carlsen, Thomas H. R., Schønning, Kristian, Christensen, Peer Brehm, Laursen, Alex Lund, Krarup, Henrik, Bukh, Jens, Weis, Nina
Gepubliceerd in 2013

Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a

door Carlsen, Thomas H.R., Pedersen, Jannie, Prentoe, Jannick C., Giang, Erick, Keck, Zhen-Yong, Mikkelsen, Lotte S., Law, Mansun, Foung, Steven K. H., Bukh, Jens
Gepubliceerd in Hepatology (2014)

Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies

door Pedersen, Jannie, Carlsen, Thomas H. R., Prentoe, Jannick, Ramirez, Santseharay, Jensen, Tanja B., Forns, Xavier, Alter, Harvey, Foung, Steven K. H., Law, Mansun, Gottwein, Judith, Weis, Nina, Bukh, Jens
Gepubliceerd in Hepatology (2013)